Evidence map›Paper›PMID 25156724›Full record

ArticleInfection and immunity2014

The subcellular location of ovalbumin in Plasmodium berghei blood stages influences the magnitude of T-cell responses.

Jing-Wen Lin, Tovah N Shaw, Takeshi Annoura, Aurélie Fougère, Pascale Bouchier, Séverine Chevalley-Maurel, Hans Kroeze, Blandine Franke-Fayard, Chris J Janse, Kevin N Couper and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Monocyte-Derived CD11cCell host & microbe · 2019
    Article
  7. Article
  8. Article
  9. Pathogenic CD8Frontiers in cellular and infection microbiology · 2017
    Article
  10. Targeting Angiotensin II Type-1 Receptor (ATFrontiers in cellular and infection microbiology · 2017
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Jing-Wen LinLeiden Malaria Research Group, Parasitology, Leiden University Medical Centre, Leiden, The Netherlands.
Tovah N ShawFaculty of Life Sciences, University of Manchester, Manchester, United Kingdom.
Takeshi AnnouraLeiden Malaria Research Group, Parasitology, Leiden University Medical Centre, Leiden, The Netherlands.
Aurélie FougèreLeiden Malaria Research Group, Parasitology, Leiden University Medical Centre, Leiden, The Netherlands.
Pascale BouchierLeiden Malaria Research Group, Parasitology, Leiden University Medical Centre, Leiden, The Netherlands.
Séverine Chevalley-MaurelLeiden Malaria Research Group, Parasitology, Leiden University Medical Centre, Leiden, The Netherlands.
Hans KroezeLeiden Malaria Research Group, Parasitology, Leiden University Medical Centre, Leiden, The Netherlands.
Blandine Franke-FayardLeiden Malaria Research Group, Parasitology, Leiden University Medical Centre, Leiden, The Netherlands.
Chris J JanseLeiden Malaria Research Group, Parasitology, Leiden University Medical Centre, Leiden, The Netherlands.
Kevin N CouperFaculty of Life Sciences, University of Manchester, Manchester, United Kingdom.
Shahid M KhanLeiden Malaria Research Group, Parasitology, Leiden University Medical Centre, Leiden, The Netherlands S.M.Khan@lumc.nl.
Leiden University · NLUniversity of Manchester · GB

Funding

Medical Research Council G0900487
6 · The paper itself

Abstract

Model antigens are frequently introduced into pathogens to study determinants that influence T-cell responses to infections. To address whether an antigen's subcellular location influences the nature and magnitude of antigen-specific T-cell responses, we generated Plasmodium berghei parasites expressing the model antigen ovalbumin (OVA) either in the parasite cytoplasm or on the parasitophorous vacuole membrane (PVM). For cytosolic expression, OVA alone or conjugated to mCherry was expressed from a strong constitutive promoter (OVAhsp70 or OVA::mCherryhsp70); for PVM expression, OVA was fused to HEP17/EXP1 (OVA::Hep17hep17). Unexpectedly, OVA expression in OVAhsp70 parasites was very low, but when OVA was fused to mCherry (OVA::mCherryhsp70), it was highly expressed. OVA expression in OVA::Hep17hep17 parasites was strong but significantly less than that in OVA::mCherryhsp70 parasites. These transgenic parasites were used to examine the effects of antigen subcellular location and expression level on the development of T-cell responses during blood-stage infections. While all OVA-expressing parasites induced activation and proliferation of OVA-specific CD8(+) T cells (OT-I) and CD4(+) T cells (OT-II), the level of activation varied: OVA::Hep17hep17 parasites induced significantly stronger splenic and intracerebral OT-I and OT-II responses than those of OVA::mCherryhsp70 parasites, but OVA::mCherryhsp70 parasites promoted stronger OT-I and OT-II responses than those of OVAhsp70 parasites. Despite lower OVA expression levels, OVA::Hep17hep17 parasites induced stronger T-cell responses than those of OVA::mCherryhsp70 parasites. These results indicate that unconjugated cytosolic OVA is not stably expressed in Plasmodium parasites and, importantly, that its cellular location and expression level influence both the induction and magnitude of parasite-specific T-cell responses. These parasites represent useful tools for studying the development and function of antigen-specific T-cell responses during malaria infection.

Indexed as

AnimalsFemaleGene Expression RegulationMalariaMiceOrganisms, Genetically ModifiedOvalbuminPlasmodium bergheiProtein TransportSpleenT-LymphocytesOvalbumin

Identifiers

PMID25156724
PMCPMC4249308
OpenAlexW2119548504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.